Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 31,983,000 $ 207,602,000
Short-term investments 48,214,000 15,483,000
Accounts receivable, net 9,185,000 12,778,000
Inventories 71,202,000 22,479,000
Contract assets 6,805,000 274,000
Prepaid expenses and other current assets 5,533,000 9,458,000
Total current assets 172,922,000 268,074,000
Property and equipment, net 19,812,000 10,046,000
Equipment on lease, net 9,070,000 8,366,000
Other assets 23,310,000 16,231,000
Total assets 225,114,000 302,717,000
Current liabilities:    
Accounts payable 12,207,000 9,882,000
Accrued expenses and other current liabilities 15,877,000 9,414,000
Debt – current portion 2,775,000 5,114,000
Contract liabilities 15,194,000 22,252,000
Total current liabilities 46,053,000 46,662,000
Long-term debt – less current portion 5,422,000 2,956,000
Contingent earnout liabilities (Note 12) 17,414,000 111,487,000
Warrant liabilities (Note 12) 2,745,000 21,705,000
Other noncurrent liabilities 12,634,000 9,492,000
Total liabilities 84,268,000 192,302,000
Commitments and contingencies (Note 15)
Stockholders' equity (deficit):    
Common stock, $0.00001 par value – 500,000,000 shares authorized at December 31, 2022 and 2021, respectively, 187,561,368 and 183,232,494 shares issued and outstanding as of December 31, 2022 and 2021, respectively 2,000 2,000
Additional paid-in capital 361,528,000 340,294,000
Accumulated other comprehensive loss (837,000) (14,000)
Accumulated deficit (219,847,000) (229,867,000)
Total stockholders’ equity 140,846,000 110,415,000
Total liabilities, redeemable convertible preferred stock and stockholders’ equity $ 225,114,000 $ 302,717,000